Point-of-Care Glucose Testing Market Growth, Size, Trends Analysis - By Product - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.

Published Mar 03, 2025

Length 255 Pages

SKU # SPER19991552

Description

Point-of-Care Glucose Testing Market Introduction and Overview

According to SPER market research, ‘Global Point-of-Care Glucose Testing Market Size- By Product – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Point-of-Care Glucose Testing Market is predicted to reach 5.36 Billion by 2034 with a CAGR 4.39%.

Point-of-care glucose testing allows for immediate blood sugar measurement at the patient’s location, rather than requiring lab analysis. This method is essential for diabetes management, a condition affecting blood glucose regulation. The testing process utilizes tools like test strips, lancets, lancing devices, and glucose meters. Rising awareness of diabetes management, limited access to healthcare, the scarcity of healthcare workers, and the highest prevalence of diabetes recorded in Asian countries are likely to increase the use of POC glucose testing solutions.

Restraints:Strict regulatory approvals, necessary for safety and accuracy, create hurdles for point-of-care diagnostic product commercialization. These rigorous processes, including testing and trials mandated by bodies like the FDA and CE marking, result in delayed market entry, high development costs, and challenges for smaller businesses.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments coveredBy Product.

Regions covered:
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered
Abbott, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc. and others.

Point-of-Care Glucose Testing Market Segmentation:

By Product:Based on the Product, Global Point-of-Care Glucose Testing Market is segmented as; Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Other.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

1. Introduction: 1.1. Scope of the report; 1.2. Market segment analysis
2. Research Methodology: 2.1. Research data source; 2.1.1. Secondary Data; 2.1.2. Primary Data; 2.1.3. SPERs internal database; 2.1.4. Premium insight from KOLs; 2.2. Market size estimation; 2.2.1. Top-down and Bottom-up approach; 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics: 4.1. Driver, Restraint, Opportunity and Challenges analysis; 4.1.1. Drivers; 4.1.2. Restraints; 4.1.3. Opportunities; 4.1.4. Challenges
5. Market variable and outlook: 5.1. SWOT Analysis; 5.1.1. Strengths; 5.1.2. Weaknesses; 5.1.3. Opportunities; 5.1.4. Threats; 5.2. PESTEL Analysis; 5.2.1. Political Landscape; 5.2.2. Economic Landscape; 5.2.3. Social Landscape; 5.2.4. Technological Landscape; 5.2.5. Environmental Landscape; 5.2.6. Legal Landscape; 5.3. PORTERs Five Forces; 5.3.1. Bargaining power of suppliers; 5.3.2. Bargaining power of buyers; 5.3.3. Threat of Substitute; 5.3.4. Threat of new entrant; 5.3.5. Competitive rivalry; 5.4. Heat Map Analysis
6. Competitive Landscape: 6.1. Global Point-of-Care Glucose Testing Market Manufacturing Base Distribution, Sales Area, Product Type; 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Point-of-Care Glucose Testing Market
7. Global Point-of-Care Glucose Testing Market, By Product, (USD Million) 2021-2034: 7.1. Accu Check Aviva Meter; 7.2. Onetouch Verio Flex; 7.3. i-STAT; 7.4. Bayer CONTOUR Blood Glucose Monitoring System; 7.5. Freestyle Lite; 7.6. True Metrix; 7.7. Accu-Chek Inform II; 7.8. StatStrip; 7.9. Others
8. Global Point-of-Care Glucose Testing Market, (USD Million) 2021-2034: 8.1. Global Point-of-Care Glucose Testing Market Size and Market Share
9. Global Point-of-Care Glucose Testing Market, By Region, (USD Million) 2021-2034: 9.1. Asia-Pacific; 9.1.1. Australia; 9.1.2. China; 9.1.3. India; 9.1.4. Japan; 9.1.5. South Korea; 9.1.6. Rest of Asia-Pacific; 9.2. Europe; 9.2.1. France; 9.2.2. Germany; 9.2.3. Italy; 9.2.4. Spain; 9.2.5. United Kingdom; 9.2.6. Rest of Europe; 9.3. Middle East and Africa; 9.3.1. Kingdom of Saudi Arabia; 9.3.2. United Arab Emirates; 9.3.3. Qatar; 9.3.4. South Africa; 9.3.5. Egypt; 9.3.6. Morocco; 9.3.7. Nigeria; 9.3.8. Rest of Middle-East and Africa; 9.4. North America; 9.4.1. Canada; 9.4.2. Mexico; 9.4.3. United States; 9.5. Latin America; 9.5.1. Argentina; 9.5.2. Brazil; 9.5.3. Rest of Latin America
10. Company Profile: 10.1. Abbott; 10.1.1. Company details; 10.1.2. Financial outlook; 10.1.3. Product summary; 10.1.4. Recent developments; 10.2. ACON Laboratories; 10.2.1. Company details; 10.2.2. Financial outlook; 10.2.3. Product summary; 10.2.4. Recent developments; 10.3. Bayer AG/Ascensia Diabetes Care Holdings AG; 10.3.1. Company details; 10.3.2. Financial outlook; 10.3.3. Product summary; 10.3.4. Recent developments; 10.4. EKF Diagnostics; 10.4.1. Company details; 10.4.2. Financial outlook; 10.4.3. Product summary; 10.4.4. Recent developments; 10.5. F. Hoffmann-La Roche Ltd.; 10.5.1. Company details; 10.5.2. Financial outlook; 10.5.3. Product summary; 10.5.4. Recent developments; 10.6. Nipro; 10.6.1. Company details; 10.6.2. Financial outlook; 10.6.3. Product summary; 10.6.4. Recent developments; 10.7. Nova Biomedical; 10.7.1. Company details; 10.7.2. Financial outlook; 10.7.3. Product summary; 10.7.4. Recent developments; 10.8. PlatInium Equity Advisors, LLC (Lifescan, Inc.); 10.8.1. Company details; 10.8.2. Financial outlook; 10.8.3. Product summary; 10.8.4. Recent developments; 10.9. Prodigy Diabetes Care, LLC; 10.9.1. Company details; 10.9.2. Financial outlook; 10.9.3. Product summary; 10.9.4. Recent developments; 10.10. Trividia Health, Inc.; 10.10.1. Company details; 10.10.2. Financial outlook; 10.10.3. Product summary; 10.10.4. Recent developments; 10.11. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links

Pricing

Currency Rates

Single User Email from Publisher $4,520
Global Site License Email from Publisher $7,450

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now